Marc Martinez-Llordella, PhD

VP Biology & Founder
Quell Therapeutics
London, England, United Kingdom

Disclosure information not submitted.

Presentation(s):

• Engineering of Regulatory T Cells with Hepatocyte-specific Chimeric Antigen Receptor Enhances Liver Tissue Trafficking

  Thursday, June 26, 2025
  5:10pm - 5:25pm East Coast USA Time

• Use of Engineered CAR-Treg Cells to Induce Immune Tolerance in Liver Transplantation – Insights from the LIBERATE Clinical Trial

  Friday, June 27, 2025
  2:25pm - 2:40pm East Coast USA Time